Stock Earnings

Question 1

What are Black Diamond Therapeutics Inc's key financial statements?

Accepted Answer

According to the latest financial statement (Form-10K), Black Diamond Therapeutics Inc has a total asset of $123, Net loss of $-70

Question 2

What are the key financial ratios for BDTX?

Accepted Answer

Black Diamond Therapeutics Inc's Current ratio is 3.15, has a Net margin is 0, sales per share of $0.

Question 3

How is Black Diamond Therapeutics Inc's revenue broken down by segment or geography?

Accepted Answer

Currently Black Diamond Therapeutics Inc data is not available.

Question 4

Is Black Diamond Therapeutics Inc profitable?

Accepted Answer

no, according to the latest financial statements, Black Diamond Therapeutics Inc has a net loss of $-70

Question 5

Does Black Diamond Therapeutics Inc have any liabilities?

Accepted Answer

yes, Black Diamond Therapeutics Inc has liability of 39

Question 6

How many outstanding shares for Black Diamond Therapeutics Inc?

Accepted Answer

Black Diamond Therapeutics Inc has a total outstanding shares of 57

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	70	0	0	0	0	0
Revenue Growth (YoY)	--	--	--	--	--	--
Cost of Revenue	--	--	--	--	--	--
Gross Profit	--	--	--	--	--	--
Selling, General & Admin	20	27	27	28	30	21
Research & Development	45	51	59	64	96	48
Operating Expenses	64	79	86	92	126	69
Other Non Operating Income (Expenses)	6	6	2	0	-2	-1
Pretax Income	14	-70	-82	-91	-125	-67
Income Tax Expense	--	0	--	--	--	--
Net Income	14	-70	-82	-91	-125	-67
Net Income Growth	-118%	-15%	-10%	-27%	87%	91%
Shares Outstanding (Diluted)	57	55	44	36.33	36.19	32.91
Shares Change (YoY)	4%	25%	21%	0%	10%	1%
EPS (Diluted)	0.23	-1.27	-1.88	-2.51	-3.47	-2.04
EPS Growth	-115.99%	-32%	-25%	-28%	70%	89%
Free Cash Flow	18	-62	-67	-85	-102	-52
Free Cash Flow Per Share	0.31	-1.12	-1.52	-2.33	-2.81	-1.58
Gross Margin	--	--	--	--	--	--
Operating Margin	8.57%	0%	0%	0%	0%	0%
Profit Margin	20%	0%	0%	0%	0%	0%
Free Cash Flow Margin	25.71%	0%	0%	0%	0%	0%
EBITDA	6	-79	-86	-92	-126	-69
EBITDA Margin	8.57%	0%	0%	0%	0%	0%
D&A For EBITDA	0	0	0	0	0	0
EBIT	6	-79	-86	-92	-126	-69
EBIT Margin	8.57%	0%	0%	0%	0%	0%
Effective Tax Rate	--	0%	--	--	--	--

Black Diamond Therapeutics Inc (BDTX) Price